Skip to content
Open access · CC-BY via OpenAlex

Role of hematopoietic aging in cognitive decline

Helen S. Goodridge

Translational Medicine of Aging · 2020 · ▲ 1 citations

Abstract

We recently demonstrated that transplantation of young bone marrow cells rescued hippocampal learning and memory in old recipient mice. Our study also implicated CCL11/eotaxin-1 in microglial reactivity during aging, which likely underlies neurotoxicity and synapse loss. CCL11 was reduced in the circulation of old recipients of young bone marrow, which likely contributed to their improved cognitive function. Thus, targeting CCL11 or its receptor may be an effective strategy for the treatment of neurodegenerative diseases such as Alzheimer’s and Parkinson’s.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1016/j.tma.2020.07.003
Canonical
link ↗
Fetched
2026-08-03 MST

Cite this

APA
Goodridge, H.S. (2020). Role of hematopoietic aging in cognitive decline. <em>Translational Medicine of Aging</em>. https://doi.org/10.1016/j.tma.2020.07.003
Vancouver
Goodridge HS. Role of hematopoietic aging in cognitive decline. Translational Medicine of Aging. 2020. doi:10.1016/j.tma.2020.07.003.
BibTeX
@article{helen2020Roleof, title = {Role of hematopoietic aging in cognitive decline}, author = {Helen S. Goodridge}, journal = {Translational Medicine of Aging}, year = {2020}, doi = {10.1016/j.tma.2020.07.003}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings